• VOD-new-1
  • linkedin
Thursday, 17 September 2015 17:30

Case Study: Basal Cell Carcinoma Post-Surgical Scar – PCCA PracaSil™-Plus

The purpose of this case study is to discuss the management of a basal cell carcinoma post-surgical scar using PracaSil-Plus in a 41-year-old Caucasian male. The POSAS Patient Scale (adapted) was the research instrument used to evaluate the efficacy of PracaSil-Plus in scar management therapy. Following PracaSil-Plus treatment, the total POSAS score decreased by 33 and the patient’s overall opinion by 6, corresponding to improvements of 76.7% and 75.0%, respectively. The post-treatment scar was no longer painful or itchy and all other parameters (color, stiffness, thickness and irregularity) were very similar to normal skin, which demonstrates a successful recovery process and a considerable improvement in the patient’s quality of life.

The POSAS Patient Scale (adapted) was the research instrument used to evaluate the efficacy of PracaSil-Plus in scar management therapy. Following PracaSil-Plus treatment, the total POSAS score decreased by 33 and the patient’s overall opinion by 6, corresponding to improvements of 76.7% and 75.0%, respectively. The post-treatment scar was no longer painful or itchy and all other parameters (color, stiffness, thickness and irregularity) were very similar to normal skin, which demonstrates a successful recovery process and a considerable improvement in the patient’s quality of life.

 

Introduction:

Basal cell carcinoma (BCC) is a type of skin cancer that arises from the uncontrolled growth of basal cells lining the deepest layer of the epidermis. There is a high incidence of BCC as over 2 million people are estimated to be diagnosed with BCC every year in the United States, with a higher prevalence in the Caucasian population. The etiology of BCC is usually associated with exposure to ultraviolet radiation in sunlight. Following diagnosis, surgical excision of the cancerous cells is the most common treatment option. Surgical excision can result in destruction of the tissues, leading to scarring and disfigurement. Unfortunately, scars cannot yet be made to disappear, and may range from a desirable fine line to a variety of abnormal scars, including hypertrophic and keloid scars. Taking into account that clinical treatments do not entirely eliminate skin scarring, the therapeutic goal is to reduce, as much as possible, the severity of the scars.

The purpose of this case study is to discuss the management of a basal cell carcinoma post-surgical scar using PracaSil-Plus, a topical silicone base containing Pracaxi oil, used alone or in combination with active pharmaceutical ingredients in scar management therapy.

Download the complete PDF detailing the results of this study.

Click to learn more about PracaSil-Plus.